This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024
Register
Menu
Register

Gregory Adams, PhD
Chief Scientific Officer at Elucida Oncology
Speaker

Agenda Sessions

  • Co-Chairs’ Remarks

    , 2:10pm
    View Session

  • First in Human Studies with ELU001, an anti-Folate Receptor Alpha Targeted C'Dot Drug Conjugate

    , 4:15pm
    View Session

At this event

Prev
Next
Juan Carlos Almagro, PhD
Founder and CEO
GlobalBio, Inc.

See Gregory at Antibody Engineering & Therapeutics US

Register